Abstract
Research data from the past decade indicate that noble gases like xenon and helium exert profound cardioprotection when applied before, during or afte r organ ischemia. Of all noble gases, especially helium, has gained interest in the past years because it does not have an anesthetic “side effect” like xenon, allowing application of this specific gas in numerous clinical ischemia/reperfusion situations. Because helium has several unique characteristics and no hemodynamic side effects, helium could be administered in severely ill patients. Investigations in animals as well as in humans have proven that this noble gas is not completely inert and can induce several biological effects. Though the underlying molecular mechanisms of helium-induced cardiac protection are still not yet fully understood, recently different signaling pathways have been elucidated.
Keywords: Cardioprotection, conditioning, helium, mechanism, noble gases.
Current Drug Targets
Title:Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium
Volume: 16 Issue: 8
Author(s): Nina C. Weber, Kirsten F. Smit, Markus W. Hollmann and Benedikt Preckel
Affiliation:
Keywords: Cardioprotection, conditioning, helium, mechanism, noble gases.
Abstract: Research data from the past decade indicate that noble gases like xenon and helium exert profound cardioprotection when applied before, during or afte r organ ischemia. Of all noble gases, especially helium, has gained interest in the past years because it does not have an anesthetic “side effect” like xenon, allowing application of this specific gas in numerous clinical ischemia/reperfusion situations. Because helium has several unique characteristics and no hemodynamic side effects, helium could be administered in severely ill patients. Investigations in animals as well as in humans have proven that this noble gas is not completely inert and can induce several biological effects. Though the underlying molecular mechanisms of helium-induced cardiac protection are still not yet fully understood, recently different signaling pathways have been elucidated.
Export Options
About this article
Cite this article as:
Weber C. Nina, Smit F. Kirsten, Hollmann W. Markus and Preckel Benedikt, Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium, Current Drug Targets 2015; 16 (8) . https://dx.doi.org/10.2174/1389450116666150120104459
DOI https://dx.doi.org/10.2174/1389450116666150120104459 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Nicotinamide Phosphoribosyltransferase as a Target in Inflammation- Related Disorders
Current Topics in Medicinal Chemistry Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Soluble Epoxide Hydrolase Inhibitors and Cardiovascular Diseases
Current Vascular Pharmacology ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets Genetics of Atherosclerosis in Murine Models
Current Drug Targets Current Management of Intermittent Claudication: The Role of Pharmacological and Nonpharmacological Symptom-Directed Therapies
Current Vascular Pharmacology Matrix Metalloproteinases and Vulnerable Atheromatous Plaque
Current Topics in Medicinal Chemistry Hypertension and Angiogenesis
Current Pharmaceutical Design Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
Current Vascular Pharmacology MRI Contrast Agents: Current Status and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Current Pharmaceutical Design Bioabsorbable Coronary Stents - Are These the Next Big Thing in Coronary Angioplasty?
Recent Patents on Cardiovascular Drug Discovery Renal Sympathetic Denervation and Renal Physiology
Current Clinical Pharmacology Subject Index To Volume 2
Current Hypertension Reviews Hypothermia and Alzheimer's Disease Neuropathogenic Pathways
Current Alzheimer Research Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes
Current Pharmaceutical Design Triple Threat: The Na+/Ca2+ Exchanger in the Pathophysiology of Cardiac Arrhythmia, Ischemia and Heart Failure
Current Drug Targets Relevance of Sphingolipids in the Pleiotropic Protective Effects of High-Density Lipoproteins
Current Pharmaceutical Design 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry